Keyphrases
Acute Myeloid Leukemia
100%
Apoptotic Pathway
100%
X-linked Inhibitor of Apoptosis Protein
100%
Simultaneous Activation
100%
Induced Apoptosis
40%
Apoptosis Inhibition
40%
P53 Activation
30%
Nutlin-3
30%
Murine Double Minute 2 (MDM2)
20%
Antisense Oligonucleotides
20%
Leukemia
10%
Cell Death
10%
Apoptosis
10%
Knockdown
10%
Induced Cell Death
10%
Short Hairpin RNA (shRNA)
10%
Stromal Cells
10%
Combination Strategy
10%
Acute Myeloid Leukemia Cells
10%
Ongoing Clinical Trials
10%
Small Molecule Antagonist
10%
Double Minutes
10%
OCI-AML3
10%
Caspase-6
10%
Second Mitochondria-derived Activator of Caspase
10%
MDM2 Antagonist
10%
P53 Wild Type
10%
Mechanistic Studies
10%
Biochemistry, Genetics and Molecular Biology
Inhibitor of Apoptosis
100%
Myeloid
100%
P53
100%
Programmed Cell Death
100%
Nutlin
30%
Oligonucleotide
20%
Antisense
20%
Cell Death
20%
Small Molecule
10%
Clinical Trial
10%
Wild Type
10%
Stromal Cell
10%
Mitochondrion
10%
down Regulation
10%
P21
10%
Caspase
10%
Small Hairpin RNA
10%
Caspase 6
10%
Small Interfering RNA
10%
Neuroscience
P53
100%
Myeloid
100%
X Linked Inhibitor of Apoptosis
100%
Programmed Cell Death
100%
Antisense Oligonucleotide
20%
Cell Death
20%
Small Hairpin RNA
10%
Caspase 6
10%
Double Minute
10%
Second Mitochondrial Activator of Caspase
10%
Pharmacology, Toxicology and Pharmaceutical Science
Protein P53
100%
X Linked Inhibitor of Apoptosis
100%
Acute Myeloid Leukemia
100%
Nutlin 3
30%
Antisense Oligonucleotide
20%
Clinical Trial
10%
Leukemia
10%
Short Hairpin RNA
10%
Caspase 6
10%
Second Mitochondrial Activator of Caspase
10%